Home › Parkinson's Disease › Virginia
Parkinson's Disease clinical trials in Virginia
10 studies for Parkinson's Disease are looking for participants at sites in Virginia.
Cities in Virginia
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-009, Henrico
- Site-074, Newport News
RecruitingPhase 2/3
Ages 40 to 80 · All sexes · Updated Sep 28, 2026 · NCT06976268A Study of Buntanetap in Participants With PD
- University of Virginia Health System (UVAHS) - Adult Neurology Clinic, Charlottesville
RecruitingPhase 2/3
Ages 40 to 85 · All sexes · Updated Sep 21, 2026 · NCT07284784A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #066, Arlington
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615Parkinson's Foundation PD GENEration Genetic Registry
- Virginia Commonwealth University, Richmond
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- University of Virginia, Charlottesville
RecruitingObservational study
Ages 45 to 75 · All sexes · Updated Sep 4, 2026 · NCT07330258A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- University of Virginia Health System, Charlottesville
- VCU Health North Hospital, Richmond
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 3, 2026 · NCT07174310A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of Virginia, Charlottesville
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Aug 28, 2026 · NCT06680830A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Virginia Commonwealth University, Richmond
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Aug 4, 2026 · NCT06944522Remote Haptic Rehabilitation for Parkinson's Disease
- Virginia Tech, Blacksburg
Recruiting
Ages 18 and older · All sexes · Updated Jun 5, 2026 · NCT07457710A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Inova Neurology, Fairfax
- VCU Parkinsons Disease and Movement Disorders Center, Henrico
- MedStar Georgetown University Hospital Department of Neurology, McLean
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 24, 2025 · NCT06765668From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.